| Date | Time | Source | Announcement |
|---|---|---|---|
| 24 Jan 2018 | 07:00 AM | NOVACYT REVENUES FULL YEAR 2017 | |
| 02 Jan 2018 | 01:30 PM | Liquidity Agreement Update and Total Voting Rights | |
| 02 Jan 2018 | 07:00 AM | PLACED IN TECHNOLOGY FAST 500 EMEA AWARDS | |
| 01 Dec 2017 | 07:00 AM | Liquidity Agreement Update and Total Voting Rights | |
| 07 Nov 2017 | 12:39 PM | Notification of major holdings | |
| 07 Nov 2017 | 07:00 AM | FOR THE SECOND YEAR RUNNING WINS FAST 50 AWARD | |
| 02 Nov 2017 | 07:00 AM | SETTLEMENT AND REDEMPTION OF CONVERTIBLE BONDS | |
| 01 Nov 2017 | 07:00 AM | ADMISSION AND FIRST DAY OF DEALINGS ON AIM |
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying an extensive range assays and reagents worldwide.
Novacyt launched on LSE in 2017 under the ticker NCYT.
Novacyt share price launched at 61p.